- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AVXL
Recent news which mentions AVXL
12 Health Care Stocks Moving In Monday's Intraday Session
November 28, 2022
From Benzinga
Dow Tumbles Over 200 Points; Axsome Therapeutics Shares Spike Higher
November 28, 2022
From Benzinga
CinCor Pharma, Anavex Life Sciences And Some Other Big Stocks Moving Lower On Monday
November 28, 2022
From Benzinga
Earnings Scheduled For November 28, 2022
November 28, 2022
From Benzinga
This Stock Is Up 106% In 2022 And Analysts Love It, But Jim Cramer Says 'There's Too Much Political Risk'
November 15, 2022
From Benzinga
Anavex Life Sciences (AVXL) Q3 2022 Earnings Call Transcript
August 09, 2022
Tickers
AVXL
From Motley Fool
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 14, 2022
From Benzinga
From Benzinga
Tickers
AVXL
From Motley Fool
Anavex Life Sciences Highlights Biomarker Data From Parkinson's Disease Dementia At International Conference
March 15, 2022
Tickers
AVXL
From Benzinga
Anavex Life Sciences (AVXL) Q1 2022 Earnings Call Transcript
February 10, 2022
Tickers
AVXL
From Motley Fool
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
February 09, 2022
From Benzinga
Earnings Scheduled For February 9, 2022
February 09, 2022
From Benzinga
23 Stocks Moving in Wednesday's Pre-Market Session
February 02, 2022
From Benzinga
52 Biggest Movers From Yesterday
February 02, 2022
From Benzinga
From Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
February 01, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 01, 2022
From Benzinga
Mid-Day Market Update: Pitney Bowes Drops After Q4 Earnings; Biofrontera Shares Climb
February 01, 2022
From Benzinga
Mid-Morning Market Update: Markets Mostly Lower Following Monday's Rally; UPS Earnings Top Views
February 01, 2022
From Benzinga
The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program
February 01, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 14, 2022
From Benzinga
Anavex Life's Neurodegenerative Disease Candidate Meets Primary Endpoint In Early-Stage Study
January 10, 2022
Tickers
AVXL
From Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
December 26, 2021
From Benzinga
Is Longeveron a Good Biotech Stock to Buy?
December 05, 2021
From Motley Fool
Anavex Life Sciences (AVXL) Q4 2021 Earnings Call Transcript
December 02, 2021
Tickers
AVXL
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.